Literature DB >> 1849146

Regulation of insulin-like growth factor (IGF) I receptor expression during muscle cell differentiation. Potential autocrine role of IGF-II.

S M Rosenthal1, A Brunetti, E J Brown, P W Mamula, I D Goldfine.   

Abstract

Muscle is an important target tissue for insulin-like growth factor (IGF) action. The presence of specific, high affinity IGF receptors, as well as the expression of IGF peptides and binding proteins by muscle suggest that a significant component of IGF action in this tissue is mediated through autocrine and/or paracrine mechanisms. To explore autocrine/paracrine action of IGFs in muscle, we studied the regulation of the IGF-I receptor and the expression of IGF peptides during differentiation of the mouse BC3H-1 muscle cell line. Differentiation from myoblasts to myocytes was associated with a 60% decrease in IGF-I receptor sites determined by Scatchard analysis. Analysis of mRNA abundance and protein labeling studies indicated that the decrease in IGF-I receptor sites was associated with similar reductions in IGF-I receptor gene expression and receptor biosynthesis. IGF-II peptide gene expression was detected in myoblasts and increased 15-fold with differentiation; the increase in IGF-II gene expression preceded the decrease in IGF-I receptor gene expression. In contrast, IGF-I peptide gene expression was low in myoblasts and decreased slightly with differentiation. To explore the potential role of endogenous IGF-II in the differentiation-associated decrease in IGF-I receptor expression, we investigated the effects of IGF-II treatment in myoblasts. The addition of IGF-II to undifferentiated myoblasts resulted in downregulation of the IGF-I receptor which was associated with decreased IGF-I receptor biosynthesis and decreased IGF-I receptor mRNA abundance. These studies suggest, therefore, that IGF-I receptor expression during muscle cell differentiation may be regulated, at least in part, through autocrine production of IGF-II.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849146      PMCID: PMC295138          DOI: 10.1172/JCI115121

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.

Authors:  M T Keating; L T Williams
Journal:  Science       Date:  1988-02-19       Impact factor: 47.728

2.  Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation.

Authors:  S E Tollefsen; R Lajara; R H McCusker; D R Clemmons; P Rotwein
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

3.  IGF-2 stimulated growth mediated by the somatomedin type 2 receptor.

Authors:  M Tally; C H Li; K Hall
Journal:  Biochem Biophys Res Commun       Date:  1987-10-29       Impact factor: 3.575

4.  Developmental regulation of the rat insulin-like growth factor I receptor gene.

Authors:  H Werner; M Woloschak; M Adamo; Z Shen-Orr; C T Roberts; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Characterisation of insulin-like growth factor I receptor in skeletal muscles of normal and insulin resistant subjects.

Authors:  N Livingston; T Pollare; H Lithell; P Arner
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

6.  Distinct biologically active receptors for insulin, insulin-like growth factor I, and insulin-like growth factor II in cultured skeletal muscle cells.

Authors:  F Beguinot; C R Kahn; A C Moses; R J Smith
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

7.  Biosynthesis and processing of the human insulin receptor.

Authors:  J Forsayeth; B Maddux; I D Goldfine
Journal:  Diabetes       Date:  1986-07       Impact factor: 9.461

8.  Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells.

Authors:  P D Lee; R L Hintz; R G Rosenfeld; W E Benitz
Journal:  In Vitro Cell Dev Biol       Date:  1988-09

9.  Insulin and insulinlike growth factor receptors and responses in cultured human muscle cells.

Authors:  M Shimizu; C Webster; D O Morgan; H M Blau; R A Roth
Journal:  Am J Physiol       Date:  1986-11

10.  The type II insulin-like growth factor (IGF) receptor has low affinity for IGF-I analogs: pleiotypic actions of IGFs on myoblasts are apparently mediated by the type I receptor.

Authors:  D Z Ewton; S L Falen; J R Florini
Journal:  Endocrinology       Date:  1987-01       Impact factor: 4.736

View more
  14 in total

1.  Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21.

Authors:  M A Lawlor; P Rotwein
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.

Authors:  S M Rosenthal; Z Q Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

3.  Ascorbic acid regulates osterix expression in osteoblasts by activation of prolyl hydroxylase and ubiquitination-mediated proteosomal degradation pathway.

Authors:  Weirong Xing; Sheila Pourteymoor; Subburaman Mohan
Journal:  Physiol Genomics       Date:  2011-04-05       Impact factor: 3.107

4.  Insulin-like growth factor-1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration.

Authors:  Domenico D'Amario; Mauricio C Cabral-Da-Silva; Hanqiao Zheng; Claudia Fiorini; Polina Goichberg; Elisabeth Steadman; João Ferreira-Martins; Fumihiro Sanada; Marco Piccoli; Donato Cappetta; David A D'Alessandro; Robert E Michler; Toru Hosoda; Luigi Anastasia; Marcello Rota; Annarosa Leri; Piero Anversa; Jan Kajstura
Journal:  Circ Res       Date:  2011-05-05       Impact factor: 17.367

5.  Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.

Authors:  F Giorgino; R J Smith
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

Authors:  D N Shapiro; B G Jones; L H Shapiro; P Dias; P J Houghton
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes.

Authors:  M Y Donath; J Zapf; M Eppenberger-Eberhardt; E R Froesch; H M Eppenberger
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

Review 8.  Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells.

Authors:  I D Goldfine; V Papa; R Vigneri; P Siiteri; S Rosenthal
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.

Authors:  G Milazzo; C C Yip; B A Maddux; R Vigneri; I D Goldfine
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Modulation of pituitary insulin-like growth factor-I bindings in rats bearing somatomammotrophic tumors.

Authors:  K Matsuo; S Yamashita; H Namba; M Niwa; S Harakawa; M Izumi; S Nagataki
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.